Appeals Court Overturns Defense Verdict from First Taxotere Hair Loss Bellwether Trial
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
Sanofi faces several new lawsuits claiming Taxotere eye problems resulted in vision damage and vision loss, which may be folded together into a new MDL for the breast cancer drug.
A second Taxotere bellwether trial over permanent hair loss has resulted in a defense verdict.
A new report indicates Merck and the FDA have received hundreds of suicide reports linked to the use of Propecia, but the drug still lacks a label warning for the…
Three Taxotere hair loss lawsuits have been selected to serve as potential fourth bellwether trials over claims the chemotherapy drug's manufacturers failed to warn patients of the risk of permanent…
A federal judge, after denying a flurry of summary judgment requests, has delayed the next Taxotere hair loss bellwether lawsuit, which was slated to go to trial in February.
A new study warns that Propecia side effects may increase the risk of suicide and other mental health problems more acutely in younger men who take the drug to reverse…
A federal judge has dismissed nearly 200 Taxotere lawsuits for being filed after the manufacturer added a warning to the label about permanent hair loss risks, but indicated the bulk…
Four bellwether trials over Taxotere hair loss claims will be held over the next two years, a federal judge has ordered.
Three claims have been chosen to serve as potential Taxotere bellwether trial cases in August 2020.